Gene Therapy Market size is expected to grow from US$ 7.94 Bn. in 2022 to US$ 44.51 Bn. by 2029, growing at a CAGR of 27.9% through 2023 to 2029. Spinal Muscular Atrophy (SMA) Indication segment leads the Global Gene Therapy Market by 2029.
Gene Therapy Market Overview:
Extensive Gene Therapy Market analysis is carried out by attentively monitoring important product positioning and the market framework's top competitors. Key competitors are profiled and their tactics are extensively examined to grasp the competitive perspective of the global Gene Therapy market.
For an in-depth analysis, click this link
Market Scope:
This research on the Gene Therapy industry is based on a thorough examination of the market, supported by secondary and primary sources. Market volume is determined by a country-by-country model mapping of Gene Therapy utilizing internal and external private information, as well as relevant patent and regulatory sources.
Gene Therapy Market Dynamics:
A strong, lightweight, and recyclable material is Gene Therapy. Additionally, it is used to make materials for food packaging as well as consumer items like CD and DVD cases. It is a low-cost, high-strength plastic that may be recycled into materials for home building, used to insulate structures, and be made into sterile disposable cutlery. The market is anticipated to grow over the course of the projected period as a result of the expanding product application scope across various end-use sectors.
The market is being driven by the expanding end markets for Gene Therapy, which include the electronics and construction sectors. The expansion of the Gene Therapy market is being driven by the rising usage of expanded Gene Therapy in building and insulation. The Gene Therapy industry will benefit from the rising construction market.
Gene Therapy Market Segmentation:
by Indication
Acute Lymphoblastic Leukemia (ALL)
Inherited Retinal Disease
Large B-cell Lymphoma
ADA-SCID
Melanoma (lesions)
Beta-Thalassemia Major/SCD
Head & Neck Squamous Cell Carcinoma
Peripheral Arterial Disease
Spinal Muscular Atrophy (SMA)
Others
Acute lymphoblastic leukemia (ALL), inherited retinal disease, large B-cell lymphoma, ADA-SCID, melanoma (lesions), beta-thalassemia major/SCD, head and neck squamous cell carcinoma, peripheral artery disease, spinal muscular atrophy (SMA), and others are the market segments based on the indication. By 2022, the Spinal Muscular Atrophy (SMA) sector had the biggest market share (41%), and by 2029, it is predicted to still be leading. One of the most common fatal genetic illnesses in children is spinal muscular atrophy (SMA). Zolgensma (AVXS-101) has been developed as a gene therapy, and its effectiveness in treating SMA and changing the disease phenotype has been shown. In May 2021, the FDA approved Zolgensma, a medication intended to address the fundamental cause of SMA, for use by Novartis.
by Vector Type
Lentivirus
AAV
Retrovirus & gamma Retrovirus
Modified Herpes Simplex Virus
Adenovirus
Non-viral Plasmid Vector
The market is divided into Lentivirus, AAV, Retrovirus & Gamma Retrovirus, Modified Herpes Simplex Virus, Adenovirus, and Non-viral Plasmid Vector categories based on the type of vector. The AAV segment is anticipated to expand quickly between 2022 and 2029, with a compound annual growth rate of 27.9%. At 43% of the market, the AAV segment had the biggest share in 2022. There will be a huge demand for AAV in the upcoming years because to its enormous development in utilization in several therapeutic domains in recent years. Their demonstrated non-pathogenicity is a major factor in their adoption. AAV viral vector-based gene therapy research and development is being conducted by a number of businesses, including Dimension Therapeutics, AGTC, Spark Therapeutics, Sangamo Biosciences, Biogen, inc.
by Delivery Method
In Vivo
Ex Vivo
by Gene Type
Antigen
Cytokine
Tumor Suppressor
Suicide
Deficiency
Growth factors
Receptors
Others
Request For Free Sample link: https://tinyurl.com/3bwc9num
Key Players:
A team of research professionals updates and amends our data regularly to reflect the most recent trends and facts. To fulfill the needs of both individual and corporate clients, we have substantial competence in research and consulting for a wide range of business disciplines. Our knowledgeable staff uses proprietary data sources as well as a range of additional approaches. The key players in the Gene Therapy business are...
1. REGENXBIO, Inc.
2. Bayer
3. Oxford BioMedica plc
4. Dimension Therapeutics, Inc.
5. Bristol-Myers Squibb Company
6. SANOFI
7. Applied Genetic Technologies Corp
8. F. Hoffmann-La Roche Ltd.
9. Bluebird Bio, Inc.
10. Novartis AG
Regional Analysis:
The study presents regional competitive circumstances. These insights help market participants improve their approaches and provide new opportunities to achieve amazing results.
Request For Free Sample link Click Here
COVID-19 Impact Analysis on Gene Therapy Market:
The spread of the COVID-19 pandemic has had a wide-ranging influence on people's lives all around the world. Markets have been forced to adopt new norms, trends, and tactics as a result. Essentially, the study report tries to paint a picture of the market's initial and future projections.
Key Questions Answered in the Gene Therapy Market Report are:
- What will be the CAGR of the Gene Therapy market during the forecast period?
- Which segment emerged as the leading segment in the Gene Therapy market?
- Which are the prominent players in the Gene Therapy market?
- What will be the Gene Therapy market size by 2027?
- Which company held the largest share in the Gene Therapy market?
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
urdu